4d Molecular Therapeutics In shares owned by Perigon Wealth Management
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Perigon Wealth Management
from 13F filings
Historical chart of Perigon Wealth Management investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Perigon Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in 4d Molecular Therapeutics In by Perigon Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.3M | 146k | 8.69 |
| 2025-06-30 | $542k | 146k | 3.71 |
| 2025-03-31 | $472k | 146k | 3.23 |
| 2024-12-31 | $684k | 146k | 4.68 |
| 2024-09-30 | $1.6M | 146k | 10.81 |
| 2024-06-30 | $3.1M | 146k | 20.99 |
| 2024-03-31 | $4.7M | 146k | 31.86 |
| 2023-12-31 | $5.0M | 246k | 20.26 |
| 2023-09-30 | $3.1M | 246k | 12.73 |
| 2023-06-30 | $4.4M | 246k | 18.07 |
| 2023-03-31 | $4.2M | 246k | 17.19 |
| 2022-12-31 | $5.5M | 246k | 22.21 |
| 2022-09-30 | $2.0M | 251k | 8.04 |
| 2022-06-30 | $2.4M | 349k | 6.98 |
| 2022-03-31 | $8.4M | 558k | 15.12 |
| 2021-12-31 | $17M | 767k | 21.94 |
| 2011-09-30 | $2.0M | 251k | 8.04 |